SPY301.52-1.45 -0.48%
DIA252.65-1.70 -0.67%
IXIC9,368.94-0.05 0.00%

KeyBanc Maintains Underweight on National Health Investors, Lowers Price Target to $40

KeyBanc maintains National Health Investors (NYSE:NHI) with a Underweight and lowers the price target from $43 to $40.

Benzinga · 05/14/2020 10:10

KeyBanc maintains National Health Investors (NYSE:NHI) with a Underweight and lowers the price target from $43 to $40.